Aimee C Chagnon, MD
Neurology · Petaluma
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 29 years
- University of California, San Francisco School of Medicine, 1997
Offices
1 location · Sonoma Pain Management, Inc · 2 clinicians in this group
Looking this up.
Hospitals listed: Petaluma Valley Hospital · Providence Queen of the Valley Medical Center · Providence Santa Rosa Memorial Hospital · Sonoma Valley Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chagnon’s office at (707) 938-7951 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A77824 · Current
Licensed to practise in California · since 2002 · expires 2027-04-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Neurology
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Petaluma Valley HospitalPetaluma, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Providence Queen of the Valley Medical CenterNapa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.107, Oct 2024 – Sep 2025
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
- Sonoma Valley HospitalSonoma, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Petaluma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.31 (0.23 to 2.39) · 147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.44 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 57 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 533 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,427 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,398 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.64 to 5.65) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.56 to 3.98) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.61 (0 to 18.36) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.16 (0.85 to 9.47) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.41) · 1,184 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.1 · 26 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.308 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3 · 143 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (9.8 to 17.8) · 364 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 138 cases | No different | Jan 2024 – Dec 2024 |
What patients said (246 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 85% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Queen of the Valley Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.107 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.92) · 609 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.5 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.43 (130.54 to 252.33) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 175 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.41) · 4,152 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,188 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (1.63 to 5.99) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.21) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.62 to 3.77) · 742 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.45 (0.91 to 16) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.58 (1.75 to 9.42) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 2,994 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.684 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.887 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.8 · 143 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.1 · 316 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1 · 399 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.4 · 337 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.5 to 7.8) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (9.8 to 17.7) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.2) · 848 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 423 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sonoma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.63 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.6 · 345 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 713 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.94) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 60 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.2 to 17.9) · 486 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 83 cases | No different | Jan 2024 – Dec 2024 |
What patients said (164 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$85,634
Medicare paid this office $85,634 for 222 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 165 | $58,473 | $134 |
| New patient visit (60+ min) | 101 | $16,708 | $165 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 80 | $3,340 | $24 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 97 | $3,141 | $12 |
| Return visit (30+ min) | 17 | $2,121 | $101 |
Who their Medicare patients are
222 Original Medicare patients in 2024. Average age 76 · Under 65 8% · 85 and older 18% · Women 58% · Also on Medicaid 5% · Health risk score 1.23. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 64% · Depression 29% · Coronary heart disease 26% · Atrial fibrillation 21% · Stroke 21% · Dementia 19% · Chronic kidney disease 18% · Cancer 16% · Diabetes 14% · Heart failure 13% · COPD 12%.
The office billed $301,206, Medicare allowed $114,400 and paid $85,634; for 981 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 222 | 981 | 76 | 1.23 | $301,206 | $85,634 |
| 2023 | 194 | 625 | 75 | 1.44 | $227,405 | $69,238 |
| 2022 | 244 | 1,219 | 74 | 1.26 | $369,288 | $141,320 |
| 2021 | 262 | 1,305 | 74 | 1.27 | $348,211 | $148,247 |
| 2020 | 281 | 1,223 | 74 | 1.39 | $326,608 | $117,012 |
| 2019 | 370 | 1,718 | 74 | 1.39 | $470,491 | $199,441 |
| 2018 | 383 | 1,621 | 74 | 1.41 | $433,173 | $170,425 |
| 2017 | 341 | 1,572 | 73 | 1.37 | $398,508 | $145,381 |
| 2016 | 343 | 1,558 | 73 | 1.28 | $421,817 | $163,100 |
| 2015 | 302 | 911 | 73 | 1.39 | $264,256 | $105,116 |
| 2014 | 295 | 902 | 72 | 1.25 | $260,910 | $103,870 |
| 2013 | 291 | 815 | 72 | 1.33 | $242,963 | $93,197 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 171 | $60,579 | $113 |
| New patient visit (60+ min) | 39 | $6,602 | $169 |
| Return visit (30+ min) | 14 | $1,160 | $68 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 27 | $775 | $26 |
2022: 4 services
| Long return visit (40+ min) | 212 | $128,838 | $120 |
| New patient visit (60+ min) | 41 | $7,155 | $175 |
| Return visit (30+ min) | 46 | $4,140 | $69 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 35 | $1,132 | $24 |
2021: 4 services
| Long return visit (40+ min) | 239 | $127,294 | $121 |
| Return visit (30+ min) | 57 | $11,569 | $80 |
| New patient visit (60+ min) | 42 | $7,550 | $180 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 38 | $1,634 | $28 |
2020: 4 services
| Long return visit (40+ min) | 255 | $93,597 | $96 |
| New patient visit (60+ min) | 50 | $8,163 | $163 |
| Extended office or other outpatient service, first hour | 50 | $8,090 | $104 |
| Return visit (30+ min) | 48 | $6,607 | $67 |
2019: 4 services
| Long return visit (40+ min) | 329 | $164,606 | $116 |
| New patient visit (60+ min) | 130 | $21,486 | $165 |
| Extended office or other outpatient service, first hour | 63 | $8,838 | $106 |
| Return visit (30+ min) | 28 | $3,298 | $92 |
2018: 7 services
| Long return visit (40+ min) | 339 | $132,146 | $107 |
| New patient visit (60+ min) | 123 | $19,229 | $156 |
| Extended office or other outpatient service, first hour | 99 | $14,667 | $100 |
| Return visit (30+ min) | 15 | $1,640 | $78 |
| Short return visit (20+ min) | 11 | $748 | $53 |
| Injection of drug or substance under skin or into muscle | 18 | $431 | $16 |
| Injection, ketorolac tromethamine, per 15 mg | 18 | $11 | None |
2017: 7 services
| Long return visit (40+ min) | 299 | $118,304 | $103 |
| New patient visit (60+ min) | 110 | $15,625 | $142 |
| Extended office or other outpatient service, first hour | 45 | $6,549 | $98 |
| Injection of drug or substance under skin or into muscle | 41 | $1,868 | $19 |
| Return visit (30+ min) | 16 | $1,408 | $70 |
| Short return visit (20+ min) | 15 | $958 | $53 |
| Injection, ketorolac tromethamine, per 15 mg | 35 | $43 | None |
2016: 6 services
| Long return visit (40+ min) | 306 | $136,255 | $109 |
| New patient visit (60+ min) | 125 | $18,652 | $149 |
| Return visit (30+ min) | 48 | $4,038 | $62 |
| Extended office or other outpatient service, first hour | 25 | $2,156 | $77 |
| Injection of drug or substance under skin or into muscle | 19 | $733 | $20 |
| Injection, ketorolac tromethamine, per 15 mg | 18 | $18 | None |
2015: 3 services
| Long return visit (40+ min) | 246 | $82,471 | $110 |
| New patient visit (60+ min) | 116 | $19,060 | $164 |
| Extended office or other outpatient service, first hour | 19 | $1,522 | $80 |
2014: 2 services
| Long return visit (40+ min) | 245 | $82,627 | $112 |
| New patient visit (60+ min) | 108 | $17,036 | $156 |
2013: 3 services
| Long return visit (40+ min) | 226 | $69,633 | $109 |
| New patient visit (60+ min) | 113 | $18,101 | $160 |
| Extended office or other outpatient service, first hour | 16 | $1,342 | $79 |
Drugs they prescribed that Part D paid
$1,000,342
Pharmacies billed $1,000,342 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 25% of their Part D prescriptions (769 of 3,142) in 2024. A higher opioid share than 9 in 10 peers; the typical neurology clinician is at 0%. Long-acting opioids: 25% of their opioid prescriptions.
2,847 generic and 295 brand-name prescriptions · $1,000,342 in drug cost · 63 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Privigen | Immune globulin | 11 | $233,751 | $21,250 |
| Dimethyl | None | 17 | $65,440 | $3,849 |
| Levorphanol | None | 13 | $63,697 | $4,900 |
| Oxycontin | None | 24 | $59,019 | $2,459 |
| Vyepti | None | 12 | $47,730 | $3,978 |
See all 72 drugs
| Privigen | Immune globulin | 11 | $233,751 | $21,250 |
| Dimethyl | None | 17 | $65,440 | $3,849 |
| Levorphanol | None | 13 | $63,697 | $4,900 |
| Oxycontin | None | 24 | $59,019 | $2,459 |
| Vyepti | None | 12 | $47,730 | $3,978 |
| Rytary | Parkinson's | 17 | $29,379 | $1,728 |
| Neupro | None | 13 | $27,045 | $2,080 |
| Buprenorphine | None | 36 | $12,864 | $357 |
| Emgality | Migraine | 16 | $10,954 | $685 |
| Lacosamide | None | 81 | $10,662 | $132 |
| Hydrocodone-Acetaminophen | None | 149 | $6,920 | $46 |
| Oxycodone | None | 170 | $6,887 | $41 |
| Reyvow | None | 12 | $6,810 | $567 |
| Fentanyl | None | 47 | $6,493 | $138 |
| Cromolyn | None | 11 | $6,442 | $586 |
| Sumatriptan | None | 30 | $5,125 | $171 |
| Morphine Sulfate | None | 109 | $4,264 | $39 |
| Memantine | None | 43 | $3,967 | $92 |
| Testosterone | None | 18 | $3,204 | $178 |
| Carbidopa-Levodopa | None | 108 | $3,090 | $29 |
| Pregabalin | None | 124 | $2,627 | $21 |
| Hydromorphone | None | 43 | $2,475 | $58 |
| Duloxetine | None | 94 | $2,288 | $24 |
| Lubiprostone | None | 17 | $2,233 | $131 |
| Gabapentin | None | 97 | $2,210 | $23 |
| Entacapone | None | 32 | $2,143 | $67 |
| Amantadine | None | 24 | $1,825 | $76 |
| Methylphenidate | None | 54 | $1,789 | $33 |
| Sumatriptan | None | 13 | $1,490 | $115 |
| Morphine Sulfate Er | None | 46 | $1,310 | $28 |
| Quetiapine | None | 59 | $989 | $17 |
| Oxycodone-Acetaminophen | None | 37 | $974 | $26 |
| Butalbital-Acetaminophen-Caffe | None | 16 | $955 | $60 |
| Rizatriptan | None | 20 | $888 | $44 |
| Primidone | None | 41 | $882 | $22 |
| Tramadol | None | 53 | $853 | $16 |
| Ropinirole | None | 19 | $782 | $41 |
| Dextroamphetamine-Amphetamine | None | 31 | $709 | $23 |
| Topiramate | None | 44 | $709 | $16 |
| Clonazepam | None | 60 | $697 | $12 |
| Baclofen | None | 37 | $657 | $18 |
| Bupropion | None | 20 | $655 | $33 |
| Zaleplon | None | 25 | $647 | $26 |
| Escitalopram | None | 52 | $628 | $12 |
| Celecoxib | None | 21 | $622 | $30 |
| Donepezil | None | 37 | $569 | $15 |
| Nortriptyline | None | 20 | $526 | $26 |
| Levetiracetam | None | 31 | $512 | $17 |
| Trazodone | None | 72 | $508 | $7 |
| Lorazepam | None | 71 | $487 | $7 |
| Fluoxetine | None | 37 | $479 | $13 |
| Pramipexole Dihydrochloride | None | 20 | $461 | $23 |
| Mirtazapine | None | 12 | $452 | $38 |
| Methadone | None | 22 | $448 | $20 |
| Propranolol | None | 18 | $406 | $23 |
| Lamotrigine | None | 13 | $402 | $31 |
| Cyclobenzaprine | None | 25 | $307 | $12 |
| Venlafaxine | None | 12 | $265 | $22 |
| Sertraline | None | 16 | $260 | $16 |
| Diazepam | None | 53 | $224 | $4 |
| Alprazolam | None | 48 | $221 | $5 |
| Carisoprodol | None | 13 | $203 | $16 |
| Eszopiclone | None | 12 | $196 | $16 |
| Zolpidem Tartrate Er | None | 14 | $196 | $14 |
| Ondansetron Odt | None | 11 | $179 | $16 |
| Indomethacin | None | 12 | $148 | $12 |
| Bupropion Xl | None | 11 | $143 | $13 |
| Tamsulosin | None | 13 | $141 | $11 |
| Zolpidem | None | 22 | $87 | $4 |
| Atorvastatin | None | 17 | $68 | $4 |
| Citalopram Hbr | None | 29 | $50 | $2 |
| Temazepam | None | 12 | $47 | $4 |
Year by year
| 2024 | 3,142 | 286 | 25% (769) | 9% | $1,000,342 |
| 2023 | 3,567 | 256 | 29% (1,032) | None | $648,664 |
| 2022 | 4,122 | 264 | 32% (1,329) | 8% | $945,222 |
| 2021 | 4,810 | 297 | 33% (1,588) | 9% | $1,157,294 |
| 2020 | 4,848 | 310 | 33% (1,616) | None | $934,396 |
| 2019 | 2,502 | 305 | 26% (656) | None | $616,163 |
| 2018 | 3,523 | 337 | 28% (1,001) | 15% | $770,800 |
| 2017 | 4,318 | 322 | 26% (1,106) | 16% | $958,724 |
| 2016 | 3,914 | 298 | 24% (924) | None | $735,334 |
| 2015 | 3,640 | 251 | 34% (1,239) | 18% | $839,860 |
| 2014 | 3,643 | 242 | 34% (1,250) | 20% | $806,685 |
| 2013 | 3,426 | 219 | 33% (1,122) | 25% | $660,433 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 77 drugs
| Avonex | None | 13 | $121,845 | $9,373 |
| Oxycontin | None | 39 | $57,090 | $1,464 |
| Dimethyl | None | 12 | $48,986 | $4,082 |
| Neupro | None | 21 | $35,840 | $1,707 |
| Buprenorphine | None | 49 | $22,598 | $461 |
| Nurtec Odt | None | 16 | $15,641 | $978 |
| Emgality | Migraine | 18 | $15,272 | $848 |
| Linzess | None | 13 | $12,164 | $936 |
| Hydrocodone-Acetaminophen | None | 251 | $10,970 | $44 |
| Belbuca | None | 12 | $10,823 | $902 |
| Oxycodone | None | 211 | $9,964 | $47 |
| Movantik | None | 16 | $9,644 | $603 |
| Emgality | Migraine | 11 | $8,296 | $754 |
| Fentanyl | None | 65 | $8,120 | $125 |
| Morphine Sulfate Er | None | 84 | $7,460 | $89 |
| Lacosamide | None | 48 | $7,152 | $149 |
| Cymbalta | None | 12 | $5,555 | $463 |
| Rivastigmine | None | 13 | $4,801 | $369 |
| Pregabalin | None | 107 | $4,200 | $39 |
| Carbidopa-Levodopa | None | 99 | $4,152 | $42 |
| Gabapentin | None | 159 | $4,018 | $25 |
| Memantine | None | 76 | $3,384 | $45 |
| Donepezil | None | 74 | $3,315 | $45 |
| Levetiracetam | None | 39 | $3,114 | $80 |
| Oxycodone-Acetaminophen | None | 87 | $2,594 | $30 |
| Testosterone | None | 19 | $2,499 | $132 |
| Duloxetine | None | 80 | $2,490 | $31 |
| Amantadine | None | 22 | $2,456 | $112 |
| Methylphenidate | None | 62 | $2,420 | $39 |
| Morphine Sulfate | None | 55 | $2,143 | $39 |
| Lamotrigine | None | 22 | $1,907 | $87 |
| Rizatriptan | None | 17 | $1,795 | $106 |
| Hydromorphone | None | 36 | $1,641 | $46 |
| Divalproex Sodium Er | None | 27 | $1,551 | $57 |
| Quetiapine | None | 68 | $1,519 | $22 |
| Topiramate | None | 49 | $1,281 | $26 |
| Sumatriptan | None | 24 | $1,246 | $52 |
| Sumatriptan | None | 12 | $1,214 | $101 |
| Celecoxib | None | 23 | $1,207 | $52 |
| Paroxetine | None | 47 | $1,105 | $24 |
| Naloxone | None | 13 | $1,031 | $79 |
| Venlafaxine | None | 11 | $877 | $80 |
| Rivastigmine | None | 20 | $816 | $41 |
| Clonazepam | None | 102 | $805 | $8 |
| Carbidopa-Levodopa Er | None | 12 | $800 | $67 |
| Methadone | None | 26 | $775 | $30 |
| Lorazepam | None | 76 | $727 | $10 |
| Divalproex | None | 19 | $727 | $38 |
| Pramipexole Dihydrochloride | None | 32 | $652 | $20 |
| Escitalopram | None | 39 | $651 | $17 |
| Ropinirole | None | 18 | $640 | $36 |
| Dextroamphetamine-Amphetamine | None | 26 | $619 | $24 |
| Trazodone | None | 63 | $599 | $10 |
| Tramadol | None | 67 | $593 | $9 |
| Carisoprodol | None | 24 | $587 | $24 |
| Lactulose | None | 13 | $578 | $44 |
| Primidone | None | 27 | $561 | $21 |
| Cyclobenzaprine | None | 19 | $526 | $28 |
| Propranolol | None | 16 | $526 | $33 |
| Nortriptyline | None | 20 | $489 | $24 |
| Fluoxetine | None | 33 | $470 | $14 |
| Clopidogrel | None | 14 | $451 | $32 |
| Baclofen | None | 27 | $431 | $16 |
| Bupropion | None | 22 | $393 | $18 |
| Acetaminophen-Codeine | None | 17 | $383 | $23 |
| Temazepam | None | 36 | $340 | $9 |
| Tizanidine | None | 22 | $308 | $14 |
| Azathioprine | None | 14 | $304 | $22 |
| Aripiprazole | None | 13 | $300 | $23 |
| Diazepam | None | 56 | $268 | $5 |
| Sertraline | None | 23 | $190 | $8 |
| Ondansetron Odt | None | 12 | $185 | $15 |
| Alprazolam | None | 64 | $167 | $3 |
| Citalopram Hbr | None | 29 | $133 | $5 |
| Prednisone | None | 11 | $89 | $8 |
| Zolpidem Tartrate Er | None | 12 | $67 | $6 |
| Zolpidem | None | 16 | $27 | $2 |
2022: 85 drugs
| Avonex | None | 12 | $130,123 | $10,844 |
| Oxycontin | None | 46 | $74,114 | $1,611 |
| Dimethyl | None | 11 | $41,386 | $3,762 |
| Neupro | None | 26 | $33,286 | $1,280 |
| Buprenorphine | None | 54 | $30,440 | $564 |
| Morphine Sulfate Er | None | 94 | $19,008 | $202 |
| Oxycodone | None | 293 | $17,974 | $61 |
| Hydrocodone-Acetaminophen | None | 345 | $15,621 | $45 |
| Emgality | Migraine | 14 | $10,597 | $757 |
| Linzess | None | 13 | $10,084 | $776 |
| Belbuca | None | 12 | $9,619 | $802 |
| Fentanyl | None | 81 | $8,063 | $100 |
| Hysingla Er | None | 11 | $7,588 | $690 |
| Movantik | None | 12 | $7,032 | $586 |
| Gabapentin | None | 215 | $4,956 | $23 |
| Carbidopa-Levodopa | None | 104 | $4,631 | $45 |
| Rivastigmine | None | 20 | $4,381 | $219 |
| Lacosamide | None | 24 | $4,026 | $168 |
| Duloxetine | None | 107 | $3,973 | $37 |
| Pregabalin | None | 125 | $3,833 | $31 |
| Oxycodone-Acetaminophen | None | 107 | $3,654 | $34 |
| Oxymorphone | None | 19 | $3,625 | $191 |
| Memantine | None | 68 | $3,611 | $53 |
| Methazolamide | None | 11 | $3,244 | $295 |
| Methylphenidate | None | 59 | $2,535 | $43 |
| Hydromorphone | None | 40 | $2,475 | $62 |
| Amantadine | None | 27 | $2,338 | $87 |
| Methadone | None | 51 | $2,031 | $40 |
| Morphine Sulfate | None | 38 | $1,966 | $52 |
| Celecoxib | None | 32 | $1,787 | $56 |
| Quetiapine | None | 49 | $1,643 | $34 |
| Donepezil | None | 65 | $1,545 | $24 |
| Tramadol | None | 106 | $1,460 | $14 |
| Rizatriptan | None | 27 | $1,417 | $52 |
| Topiramate | None | 42 | $1,416 | $34 |
| Pramipexole Dihydrochloride | None | 44 | $1,399 | $32 |
| Testosterone | None | 17 | $1,398 | $82 |
| Tizanidine | None | 52 | $1,303 | $25 |
| Trazodone | None | 79 | $1,236 | $16 |
| Naloxone | None | 13 | $1,111 | $85 |
| Levetiracetam | None | 35 | $984 | $28 |
| Diclofenac | None | 15 | $953 | $64 |
| Cyclobenzaprine | None | 31 | $856 | $28 |
| Mirtazapine | None | 21 | $839 | $40 |
| Rivastigmine | None | 21 | $838 | $40 |
| Methocarbamol | None | 11 | $827 | $75 |
| Ropinirole | None | 19 | $798 | $42 |
| Lactulose | None | 16 | $795 | $50 |
| Baclofen | None | 25 | $781 | $31 |
| Lamotrigine | None | 32 | $771 | $24 |
| Dextroamphetamine-Amphetamine | None | 40 | $726 | $18 |
| Divalproex | None | 18 | $715 | $40 |
| Ondansetron | None | 14 | $681 | $49 |
| Clonazepam | None | 108 | $658 | $6 |
| Primidone | None | 23 | $625 | $27 |
| Propranolol | None | 18 | $569 | $32 |
| Sertraline | None | 24 | $567 | $24 |
| Carisoprodol | None | 18 | $561 | $31 |
| Nortriptyline | None | 32 | $550 | $17 |
| Fluoxetine | None | 40 | $547 | $14 |
| Naratriptan | None | 12 | $501 | $42 |
| Temazepam | None | 44 | $495 | $11 |
| Paroxetine | None | 32 | $489 | $15 |
| Lorazepam | None | 88 | $479 | $5 |
| Atorvastatin | None | 13 | $472 | $36 |
| Sumatriptan | None | 23 | $469 | $20 |
| Zolpidem | None | 36 | $433 | $12 |
| Acetaminophen-Codeine | None | 17 | $433 | $25 |
| Bupropion | None | 26 | $428 | $16 |
| Carbidopa-Levodopa Er | None | 17 | $377 | $22 |
| Escitalopram | None | 11 | $373 | $34 |
| Diazepam | None | 74 | $361 | $5 |
| Hydroxyzine | None | 13 | $324 | $25 |
| Ondansetron Odt | None | 12 | $324 | $27 |
| Clopidogrel | None | 11 | $284 | $26 |
| Naproxen | None | 11 | $282 | $26 |
| Promethazine | None | 12 | $224 | $19 |
| Alprazolam | None | 58 | $221 | $4 |
| Metoclopramide | None | 13 | $211 | $16 |
| Prednisone | None | 11 | $202 | $18 |
| Zolpidem Tartrate Er | None | 13 | $194 | $15 |
| Prochlorperazine Maleate | None | 15 | $189 | $13 |
| Phenobarbital | None | 13 | $185 | $14 |
| Citalopram Hbr | None | 11 | $84 | $8 |
| Meloxicam | None | 11 | $59 | $5 |
2021: 87 drugs
| Avonex | None | 11 | $102,907 | $9,355 |
| Oxycontin | None | 50 | $74,486 | $1,490 |
| Vimpat | None | 41 | $54,332 | $1,325 |
| Xtampza Er | None | 16 | $44,203 | $2,763 |
| Buprenorphine | None | 52 | $31,352 | $603 |
| Morphine Sulfate Er | None | 126 | $20,383 | $162 |
| Hydrocodone-Acetaminophen | None | 393 | $20,278 | $52 |
| Neupro | None | 17 | $19,152 | $1,127 |
| Oxycodone | None | 346 | $16,564 | $48 |
| Linzess | None | 13 | $15,384 | $1,183 |
| Emgality | Migraine | 21 | $15,023 | $715 |
| Fentanyl | None | 105 | $11,551 | $110 |
| Carbidopa-Levodopa | None | 110 | $8,634 | $78 |
| Movantik | None | 11 | $8,400 | $764 |
| Oxycodone-Acetaminophen | None | 140 | $8,180 | $58 |
| Gabapentin | None | 264 | $7,998 | $30 |
| Cymbalta | None | 13 | $7,230 | $556 |
| Hydromorphone | None | 89 | $6,016 | $68 |
| Rasagiline Mesylate | None | 16 | $5,888 | $368 |
| Pregabalin | None | 133 | $5,766 | $43 |
| Oxymorphone | None | 22 | $5,548 | $252 |
| Methylphenidate | None | 95 | $4,764 | $50 |
| Duloxetine | None | 129 | $4,440 | $34 |
| Myrbetriq | None | 11 | $4,410 | $401 |
| Rivastigmine | None | 13 | $4,139 | $318 |
| Levetiracetam | None | 28 | $3,286 | $117 |
| Testosterone | None | 26 | $2,969 | $114 |
| Morphine Sulfate | None | 43 | $2,566 | $60 |
| Methadone | None | 73 | $2,543 | $35 |
| Dantrolene | None | 13 | $2,495 | $192 |
| Pramipexole Dihydrochloride | None | 52 | $2,428 | $47 |
| Topiramate | None | 43 | $2,368 | $55 |
| Memantine | None | 56 | $2,307 | $41 |
| Methylphenidate La | None | 14 | $2,128 | $152 |
| Tizanidine | None | 75 | $2,105 | $28 |
| Carbamazepine Er | None | 12 | $2,099 | $175 |
| Diclofenac | None | 26 | $1,943 | $75 |
| Dextroamphetamine-Amphetamine | None | 53 | $1,884 | $36 |
| Celecoxib | None | 31 | $1,839 | $59 |
| Quetiapine | None | 34 | $1,577 | $46 |
| Donepezil | None | 57 | $1,477 | $26 |
| Clonazepam | None | 157 | $1,443 | $9 |
| Rizatriptan | None | 24 | $1,439 | $60 |
| Memantine Hcl Er | None | 14 | $1,400 | $100 |
| Methocarbamol | None | 38 | $1,386 | $36 |
| Tramadol | None | 106 | $1,380 | $13 |
| Propranolol | None | 17 | $1,305 | $77 |
| Bupropion | None | 29 | $1,250 | $43 |
| Carbidopa-Levodopa Er | None | 15 | $1,221 | $81 |
| Lamotrigine | None | 73 | $1,201 | $16 |
| Amantadine | None | 11 | $1,185 | $108 |
| Nortriptyline | None | 41 | $1,056 | $26 |
| Trazodone | None | 77 | $1,037 | $13 |
| Temazepam | None | 55 | $1,033 | $19 |
| Lorazepam | None | 126 | $1,008 | $8 |
| Ondansetron | None | 17 | $939 | $55 |
| Primidone | None | 35 | $887 | $25 |
| Aripiprazole | None | 24 | $886 | $37 |
| Baclofen | None | 26 | $855 | $33 |
| Ropinirole | None | 15 | $819 | $55 |
| Cyclobenzaprine | None | 32 | $798 | $25 |
| Mirtazapine | None | 13 | $778 | $60 |
| Alprazolam | None | 76 | $753 | $10 |
| Bupropion Xl | None | 16 | $714 | $45 |
| Lactulose | None | 19 | $654 | $34 |
| Zolpidem | None | 50 | $649 | $13 |
| Sertraline | None | 41 | $648 | $16 |
| Diazepam | None | 80 | $643 | $8 |
| Ondansetron Odt | None | 20 | $624 | $31 |
| Fluoxetine | None | 20 | $618 | $31 |
| Escitalopram | None | 28 | $604 | $22 |
| Butalbital-Acetaminophen-Caffe | None | 11 | $592 | $54 |
| Rivastigmine | None | 17 | $486 | $29 |
| Paroxetine | None | 31 | $433 | $14 |
| Acetaminophen-Codeine | None | 12 | $427 | $36 |
| Hydroxyzine | None | 18 | $399 | $22 |
| Levothyroxine | None | 18 | $359 | $20 |
| Phenytoin Sodium Extended | None | 12 | $313 | $26 |
| Pantoprazole | None | 15 | $260 | $17 |
| Sumatriptan | None | 21 | $245 | $12 |
| Prednisone | None | 16 | $218 | $14 |
| Carisoprodol | None | 26 | $209 | $8 |
| Tamsulosin | None | 11 | $183 | $17 |
| Phenobarbital | None | 12 | $164 | $14 |
| Metoclopramide | None | 13 | $126 | $10 |
| Omeprazole | None | 16 | $109 | $7 |
| Citalopram Hbr | None | 14 | $88 | $6 |
2020: 88 drugs
| Oxycontin | None | 86 | $124,041 | $1,442 |
| Gilenya | None | 12 | $103,219 | $8,602 |
| Avonex | None | 11 | $79,280 | $7,207 |
| Vimpat | None | 32 | $43,509 | $1,360 |
| Buprenorphine | None | 55 | $32,464 | $590 |
| Morphine Sulfate Er | None | 133 | $19,674 | $148 |
| Hydrocodone-Acetaminophen | None | 340 | $17,955 | $53 |
| Neupro | None | 19 | $17,858 | $940 |
| Oxycodone | None | 327 | $16,041 | $49 |
| Fentanyl | None | 108 | $14,683 | $136 |
| Rasagiline Mesylate | None | 25 | $13,030 | $521 |
| Linzess | None | 17 | $13,027 | $766 |
| Aimovig | Migraine | 20 | $12,253 | $613 |
| Oxycodone-Acetaminophen | None | 159 | $10,385 | $65 |
| Hysingla Er | None | 14 | $9,134 | $652 |
| Oxymorphone | None | 34 | $8,935 | $263 |
| Carbidopa-Levodopa | None | 113 | $8,387 | $74 |
| Eliquis | None | 16 | $7,721 | $483 |
| Gabapentin | None | 252 | $7,187 | $29 |
| Hydromorphone | None | 117 | $6,768 | $58 |
| Pregabalin | None | 104 | $6,239 | $60 |
| Diclofenac | None | 105 | $5,254 | $50 |
| Methylphenidate | None | 107 | $4,708 | $44 |
| Pramipexole Dihydrochloride | None | 27 | $4,366 | $162 |
| Viibryd | None | 14 | $4,198 | $300 |
| Methadone | None | 76 | $3,365 | $44 |
| Duloxetine | None | 110 | $3,238 | $29 |
| Tizanidine | None | 89 | $3,114 | $35 |
| Rivastigmine | None | 14 | $3,018 | $216 |
| Carbidopa-Levodopa Er | None | 36 | $2,860 | $79 |
| Morphine Sulfate | None | 57 | $2,838 | $50 |
| Dantrolene | None | 16 | $2,656 | $166 |
| Methylphenidate La | None | 16 | $2,603 | $163 |
| Memantine | None | 56 | $2,335 | $42 |
| Ropinirole | None | 16 | $2,268 | $142 |
| Celecoxib | None | 31 | $2,250 | $73 |
| Testosterone | None | 11 | $2,156 | $196 |
| Quetiapine | None | 42 | $1,844 | $44 |
| Lamotrigine | None | 99 | $1,833 | $19 |
| Memantine Hcl Er | None | 14 | $1,807 | $129 |
| Donepezil | None | 57 | $1,759 | $31 |
| Mirtazapine | None | 19 | $1,435 | $76 |
| Bupropion | None | 27 | $1,416 | $52 |
| Primidone | None | 56 | $1,407 | $25 |
| Carbamazepine | None | 18 | $1,390 | $77 |
| Butalbital-Acetaminophen-Caffe | None | 31 | $1,306 | $42 |
| Trazodone | None | 63 | $1,180 | $19 |
| Clonazepam | None | 142 | $1,109 | $8 |
| Dextroamphetamine-Amphetamine | None | 31 | $1,096 | $35 |
| Propranolol | None | 14 | $1,051 | $75 |
| Lorazepam | None | 160 | $1,033 | $6 |
| Tramadol | None | 87 | $963 | $11 |
| Temazepam | None | 59 | $948 | $16 |
| Topiramate | None | 39 | $934 | $24 |
| Alprazolam | None | 82 | $921 | $11 |
| Sumatriptan | None | 34 | $844 | $25 |
| Rizatriptan | None | 13 | $717 | $55 |
| Levetiracetam | None | 21 | $696 | $33 |
| Cyclobenzaprine | None | 45 | $636 | $14 |
| Sertraline | None | 51 | $634 | $12 |
| Azathioprine | None | 15 | $607 | $40 |
| Baclofen | None | 22 | $587 | $27 |
| Diazepam | None | 69 | $543 | $8 |
| Fluoxetine | None | 16 | $529 | $33 |
| Ondansetron Odt | None | 13 | $516 | $40 |
| Ondansetron | None | 12 | $468 | $39 |
| Acetaminophen-Codeine | None | 12 | $462 | $38 |
| Paroxetine | None | 35 | $452 | $13 |
| Rivastigmine | None | 13 | $446 | $34 |
| Methocarbamol | None | 28 | $442 | $16 |
| Nortriptyline | None | 20 | $436 | $22 |
| Benztropine Mesylate | None | 16 | $405 | $25 |
| Levothyroxine | None | 21 | $374 | $18 |
| Divalproex | None | 13 | $345 | $27 |
| Phenytoin Sodium Extended | None | 12 | $336 | $28 |
| Lactulose | None | 14 | $321 | $23 |
| Escitalopram | None | 34 | $292 | $9 |
| Ketorolac Tromethamine | None | 14 | $262 | $19 |
| Clopidogrel | None | 11 | $216 | $20 |
| Methylprednisolone | None | 17 | $208 | $12 |
| Zolpidem | None | 27 | $200 | $7 |
| Lansoprazole | None | 12 | $198 | $16 |
| Risperidone | None | 11 | $190 | $17 |
| Tamsulosin | None | 11 | $169 | $15 |
| Prednisone | None | 18 | $161 | $9 |
| Pantoprazole | None | 13 | $159 | $12 |
| Clonidine | None | 16 | $93 | $6 |
| Omeprazole | None | 12 | $80 | $7 |
2019: 64 drugs
| Gilenya | 11 | $91,581 | $8,326 |
| Oxycontin | 24 | $38,750 | $1,615 |
| Vimpat | 18 | $23,307 | $1,295 |
| Lyrica | 32 | $23,038 | $720 |
| Neupro | 11 | $14,379 | $1,307 |
| Linzess | 11 | $11,234 | $1,021 |
| Memantine Hcl Er | 32 | $8,883 | $278 |
| Fentanyl | 69 | $8,831 | $128 |
| Belbuca | 19 | $8,600 | $453 |
| Morphine Sulfate Er | 52 | $7,992 | $154 |
| Hydrocodone-Acetaminophen | 148 | $6,797 | $46 |
| Oxycodone | 118 | $6,126 | $52 |
| Buprenorphine | 11 | $5,638 | $513 |
| Carbidopa-Levodopa | 81 | $5,499 | $68 |
| Entacapone | 13 | $4,488 | $345 |
| Diclofenac | 40 | $4,359 | $109 |
| Viibryd | 15 | $4,327 | $288 |
| Oxycodone-Acetaminophen | 57 | $4,207 | $74 |
| Donepezil | 62 | $2,663 | $43 |
| Gabapentin | 94 | $2,537 | $27 |
| Oxymorphone | 11 | $2,150 | $195 |
| Methylphenidate | 52 | $2,005 | $39 |
| Celecoxib | 24 | $1,915 | $80 |
| Dantrolene | 12 | $1,873 | $156 |
| Duloxetine | 53 | $1,842 | $35 |
| Pramipexole Dihydrochloride | 17 | $1,744 | $103 |
| Tizanidine | 90 | $1,684 | $19 |
| Levetiracetam | 11 | $1,673 | $152 |
| Carbidopa-Levodopa Er | 13 | $1,611 | $124 |
| Bupropion | 32 | $1,486 | $46 |
| Pregabalin | 20 | $1,438 | $72 |
| Memantine | 20 | $1,358 | $68 |
| Quetiapine | 26 | $1,325 | $51 |
| Hydromorphone | 24 | $1,288 | $54 |
| Aripiprazole | 12 | $1,262 | $105 |
| Topiramate | 42 | $1,213 | $29 |
| Morphine Sulfate | 22 | $1,195 | $54 |
| Tramadol | 59 | $1,147 | $19 |
| Primidone | 31 | $1,080 | $35 |
| Propranolol | 31 | $961 | $31 |
| Lansoprazole | 15 | $957 | $64 |
| Fluoxetine | 25 | $892 | $36 |
| Lamotrigine | 34 | $777 | $23 |
| Phenytoin Sodium Extended | 14 | $708 | $51 |
| Sertraline | 43 | $681 | $16 |
| Methadone | 21 | $566 | $27 |
| Rivastigmine | 12 | $524 | $44 |
| Clonazepam | 32 | $507 | $16 |
| Carbamazepine | 13 | $499 | $38 |
| Lorazepam | 67 | $497 | $7 |
| Bupropion Xl | 15 | $474 | $32 |
| Modafinil | 11 | $380 | $35 |
| Sumatriptan | 13 | $369 | $28 |
| Azathioprine | 12 | $317 | $26 |
| Nortriptyline | 24 | $312 | $13 |
| Ketorolac Tromethamine | 21 | $311 | $15 |
| Paroxetine | 28 | $309 | $11 |
| Alprazolam | 27 | $290 | $11 |
| Escitalopram | 21 | $288 | $14 |
| Trazodone | 31 | $257 | $8 |
| Temazepam | 25 | $219 | $9 |
| Trihexyphenidyl | 15 | $198 | $13 |
| Zolpidem | 19 | $137 | $7 |
| Diazepam | 13 | $113 | $9 |
2018: 80 drugs
| Oxycontin | 43 | $71,969 | $1,674 |
| Vimpat | 31 | $31,946 | $1,031 |
| Lyrica | 43 | $25,937 | $603 |
| Neupro | 13 | $15,104 | $1,162 |
| Oxymorphone Hcl Er | 20 | $14,970 | $749 |
| Morphine Sulfate Er | 95 | $13,667 | $144 |
| Fentanyl | 104 | $12,604 | $121 |
| Oxycodone | 195 | $11,788 | $60 |
| Butrans | 16 | $11,320 | $708 |
| Linzess | 19 | $11,206 | $590 |
| Hydrocodone-Acetaminophen | 196 | $10,513 | $54 |
| Oxycodone-Acetaminophen | 94 | $8,999 | $96 |
| Carbidopa-Levodopa | 131 | $7,309 | $56 |
| Gabapentin | 144 | $5,632 | $39 |
| Aripiprazole | 36 | $5,268 | $146 |
| Duloxetine | 81 | $5,202 | $64 |
| Oxymorphone | 15 | $4,998 | $333 |
| Maxalt Mlt | 11 | $4,923 | $448 |
| Diclofenac | 27 | $4,335 | $161 |
| Carbidopa-Levodopa Er | 22 | $2,987 | $136 |
| Hydromorphone | 50 | $2,931 | $59 |
| Quetiapine | 32 | $2,522 | $79 |
| Donepezil | 58 | $2,260 | $39 |
| Memantine | 19 | $2,185 | $115 |
| Tizanidine | 91 | $2,078 | $23 |
| Dantrolene | 12 | $1,873 | $156 |
| Methylphenidate | 42 | $1,743 | $42 |
| Pramipexole Dihydrochloride | 28 | $1,607 | $57 |
| Celecoxib | 25 | $1,589 | $64 |
| Lamotrigine | 73 | $1,526 | $21 |
| Topiramate | 73 | $1,509 | $21 |
| Methadone | 51 | $1,285 | $25 |
| Propranolol | 32 | $1,256 | $39 |
| Fluoxetine | 45 | $1,229 | $27 |
| Morphine Sulfate | 46 | $1,121 | $24 |
| Venlafaxine | 13 | $1,063 | $82 |
| Bupropion Xl | 21 | $1,027 | $49 |
| Hydroxyzine | 14 | $891 | $64 |
| Clonazepam | 60 | $885 | $15 |
| Bupropion Hcl Sr | 19 | $885 | $47 |
| Dextroamphetamine-Amphetamine | 18 | $857 | $48 |
| Tramadol | 45 | $829 | $18 |
| Bupropion | 15 | $807 | $54 |
| Primidone | 36 | $791 | $22 |
| Nortriptyline | 28 | $730 | $26 |
| Sertraline | 46 | $707 | $15 |
| Lorazepam | 79 | $690 | $9 |
| Ondansetron Odt | 12 | $632 | $53 |
| Baclofen | 24 | $618 | $26 |
| Escitalopram | 29 | $576 | $20 |
| Phenytoin Sodium Extended | 11 | $576 | $52 |
| Sinemet Cr | 13 | $559 | $43 |
| Oxcarbazepine | 13 | $537 | $41 |
| Alprazolam | 33 | $479 | $15 |
| Trazodone | 38 | $470 | $12 |
| Sumatriptan | 27 | $430 | $16 |
| Levothyroxine | 25 | $428 | $17 |
| Rizatriptan | 21 | $427 | $20 |
| Tamsulosin | 23 | $402 | $17 |
| Carbamazepine | 12 | $389 | $32 |
| Ketorolac Tromethamine | 23 | $374 | $16 |
| Cyclobenzaprine | 23 | $371 | $16 |
| Carisoprodol | 23 | $360 | $16 |
| Paroxetine | 17 | $347 | $20 |
| Benztropine Mesylate | 11 | $341 | $31 |
| Meloxicam | 32 | $321 | $10 |
| Eszopiclone | 12 | $311 | $26 |
| Ibu | 11 | $268 | $24 |
| Temazepam | 26 | $265 | $10 |
| Zolpidem | 31 | $244 | $8 |
| Diazepam | 24 | $236 | $10 |
| Phenobarbital | 12 | $219 | $18 |
| Divalproex | 13 | $174 | $13 |
| Risperidone | 13 | $173 | $13 |
| Pantoprazole | 12 | $153 | $13 |
| Trihexyphenidyl | 12 | $151 | $13 |
| Prednisone | 12 | $128 | $11 |
| Indomethacin | 11 | $115 | $10 |
| Clonidine | 12 | $88 | $7 |
| Omeprazole | 11 | $59 | $5 |
2017: 96 drugs
| Tecfidera | 15 | $126,416 | $8,428 |
| Gilenya | 12 | $87,913 | $7,326 |
| Oxycontin | 49 | $72,726 | $1,484 |
| Vimpat | 51 | $47,625 | $934 |
| Opana Er | 16 | $28,732 | $1,796 |
| Lyrica | 47 | $27,058 | $576 |
| Oxycodone Hcl Er | 15 | $26,232 | $1,749 |
| Butrans | 33 | $20,873 | $633 |
| Neupro | 19 | $20,311 | $1,069 |
| Morphine Sulfate Er | 90 | $19,652 | $218 |
| Fentanyl | 145 | $18,855 | $130 |
| Oxycodone | 204 | $14,316 | $70 |
| Rasagiline Mesylate | 19 | $13,199 | $695 |
| Oxycodone-Acetaminophen | 98 | $11,966 | $122 |
| Linzess | 27 | $10,889 | $403 |
| Namenda Xr | 11 | $10,072 | $916 |
| Androgel | 13 | $10,018 | $771 |
| Carbidopa-Levodopa | 148 | $7,865 | $53 |
| Cymbalta | 32 | $7,062 | $221 |
| Hydrocodone-Acetaminophen | 173 | $6,310 | $36 |
| Olanzapine-Fluoxetine | 12 | $6,274 | $523 |
| Aripiprazole | 42 | $6,029 | $144 |
| Gabapentin | 181 | $5,525 | $31 |
| Maxalt Mlt | 12 | $5,413 | $451 |
| Hysingla Er | 12 | $5,123 | $427 |
| Amitiza | 16 | $4,878 | $305 |
| Carbidopa-Levodopa Er | 51 | $4,296 | $84 |
| Duloxetine | 97 | $3,687 | $38 |
| Diclofenac | 29 | $3,538 | $122 |
| Hydromorphone | 48 | $3,290 | $69 |
| Methylphenidate Er | 23 | $3,006 | $131 |
| Tizanidine | 120 | $2,886 | $24 |
| Levetiracetam | 43 | $2,403 | $56 |
| Dilantin | 16 | $2,367 | $148 |
| Entacapone | 15 | $2,361 | $157 |
| Methylphenidate | 48 | $2,251 | $47 |
| Pramipexole Dihydrochloride | 49 | $2,155 | $44 |
| Quetiapine | 38 | $2,120 | $56 |
| Ropinirole Er | 23 | $1,959 | $85 |
| Esomeprazole Magnesium | 12 | $1,955 | $163 |
| Methadone | 55 | $1,718 | $31 |
| Bupropion Xl | 26 | $1,680 | $65 |
| Topiramate | 62 | $1,568 | $25 |
| Celecoxib | 17 | $1,527 | $90 |
| Venlafaxine | 20 | $1,500 | $75 |
| Propranolol | 34 | $1,463 | $43 |
| Morphine Sulfate | 57 | $1,338 | $23 |
| Lorazepam | 114 | $1,303 | $11 |
| Levothyroxine | 67 | $1,293 | $19 |
| Carbamazepine Er | 13 | $1,262 | $97 |
| Clonazepam | 105 | $1,226 | $12 |
| Tramadol | 80 | $1,225 | $15 |
| Baclofen | 45 | $1,216 | $27 |
| Clonidine | 15 | $1,203 | $80 |
| Dextroamphetamine-Amphetamine | 29 | $1,114 | $38 |
| Mirtazapine | 15 | $1,110 | $74 |
| Lamotrigine | 78 | $1,067 | $14 |
| Oxcarbazepine | 23 | $1,064 | $46 |
| Midodrine | 13 | $1,060 | $82 |
| Donepezil | 64 | $1,058 | $17 |
| Hydroxyzine | 37 | $1,038 | $28 |
| Trazodone | 70 | $802 | $11 |
| Proair Hfa | 12 | $788 | $66 |
| Alprazolam | 68 | $776 | $11 |
| Sertraline | 41 | $712 | $17 |
| Fludrocortisone Acetate | 24 | $698 | $29 |
| Escitalopram | 47 | $645 | $14 |
| Primidone | 17 | $623 | $37 |
| Sumatriptan | 31 | $518 | $17 |
| Acetaminophen-Codeine | 14 | $512 | $37 |
| Phenytoin Sodium Extended | 11 | $467 | $42 |
| Lidocaine | 11 | $441 | $40 |
| Bupropion Hcl Sr | 24 | $418 | $17 |
| Fluoxetine | 24 | $392 | $16 |
| Carisoprodol | 42 | $390 | $9 |
| Paroxetine | 17 | $374 | $22 |
| Citalopram Hbr | 45 | $363 | $8 |
| Azathioprine | 12 | $362 | $30 |
| Nitrofurantoin Mono-Macro | 11 | $346 | $31 |
| Zolpidem | 30 | $297 | $10 |
| Cyclobenzaprine | 21 | $276 | $13 |
| Ondansetron | 22 | $272 | $12 |
| Divalproex | 13 | $265 | $20 |
| Tamsulosin | 13 | $247 | $19 |
| Pantoprazole | 13 | $241 | $19 |
| Risperidone | 14 | $225 | $16 |
| Diazepam | 42 | $223 | $5 |
| Prochlorperazine Maleate | 20 | $220 | $11 |
| Phenobarbital | 12 | $211 | $18 |
| Trihexyphenidyl | 12 | $145 | $12 |
| Temazepam | 26 | $140 | $5 |
| Prednisone | 16 | $134 | $8 |
| Clonidine | 16 | $123 | $8 |
| Meloxicam | 18 | $98 | $5 |
| Ketorolac Tromethamine | 11 | $96 | $9 |
| Spironolactone | 15 | $51 | $3 |
2016: 85 drugs
| Tecfidera | 16 | $153,299 | $9,581 |
| Oxycontin | 56 | $79,081 | $1,412 |
| Lyrica | 56 | $29,169 | $521 |
| Azilect | 30 | $28,401 | $947 |
| Vimpat | 30 | $25,161 | $839 |
| Opana Er | 24 | $24,964 | $1,040 |
| Fentanyl | 120 | $16,521 | $138 |
| Butrans | 29 | $15,492 | $534 |
| Oxycodone-Acetaminophen | 115 | $14,808 | $129 |
| Neupro | 14 | $11,965 | $855 |
| Oxycodone | 162 | $11,852 | $73 |
| Androgel | 14 | $11,259 | $804 |
| Effexor Xr | 11 | $10,451 | $950 |
| Morphine Sulfate Er | 41 | $9,982 | $243 |
| Hydrocodone-Acetaminophen | 146 | $8,638 | $59 |
| Namenda Xr | 19 | $8,503 | $448 |
| Gabapentin | 207 | $6,006 | $29 |
| Exelon | 11 | $5,730 | $521 |
| Carbidopa-Levodopa | 154 | $5,424 | $35 |
| Duloxetine | 98 | $5,375 | $55 |
| Voltaren | 12 | $5,018 | $418 |
| Maxalt Mlt | 11 | $4,837 | $440 |
| Carbidopa-Levodopa Er | 57 | $4,639 | $81 |
| Entacapone | 14 | $4,512 | $322 |
| Aripiprazole | 20 | $4,294 | $215 |
| Hydromorphone | 67 | $3,995 | $60 |
| Pramipexole Dihydrochloride | 58 | $3,238 | $56 |
| Lidocaine | 17 | $3,229 | $190 |
| Donepezil | 63 | $3,090 | $49 |
| Cymbalta | 12 | $3,086 | $257 |
| Methylphenidate | 46 | $2,802 | $61 |
| Tizanidine | 81 | $2,349 | $29 |
| Eszopiclone | 21 | $2,231 | $106 |
| Levetiracetam | 46 | $2,214 | $48 |
| Venlafaxine | 25 | $2,144 | $86 |
| Clonazepam | 113 | $2,037 | $18 |
| Methadone | 49 | $1,898 | $39 |
| Ropinirole Er | 21 | $1,875 | $89 |
| Morphine Sulfate | 41 | $1,692 | $41 |
| Lorazepam | 107 | $1,507 | $14 |
| Topiramate | 67 | $1,393 | $21 |
| Galantamine Er | 12 | $1,381 | $115 |
| Propranolol | 34 | $1,301 | $38 |
| Quetiapine | 43 | $1,266 | $29 |
| Levothyroxine | 58 | $1,227 | $21 |
| Tramadol | 70 | $1,196 | $17 |
| Mirtazapine | 34 | $1,067 | $31 |
| Lamotrigine | 79 | $1,030 | $13 |
| Clonidine | 14 | $1,028 | $73 |
| Alprazolam | 80 | $998 | $12 |
| Baclofen | 40 | $978 | $24 |
| Cyproheptadine | 12 | $962 | $80 |
| Dextroamphetamine-Amphetamine | 13 | $934 | $72 |
| Oxcarbazepine | 27 | $927 | $34 |
| Dilantin | 11 | $872 | $79 |
| Sertraline | 42 | $836 | $20 |
| Escitalopram | 72 | $750 | $10 |
| Bupropion Xl | 11 | $700 | $64 |
| Bupropion | 18 | $637 | $35 |
| Divalproex | 19 | $544 | $29 |
| Trazodone | 45 | $537 | $12 |
| Prochlorperazine Maleate | 32 | $522 | $16 |
| Primidone | 19 | $518 | $27 |
| Hydroxyzine | 22 | $471 | $21 |
| Carisoprodol | 39 | $449 | $12 |
| Fluoxetine | 17 | $424 | $25 |
| Sumatriptan | 25 | $423 | $17 |
| Lansoprazole | 12 | $408 | $34 |
| Tamsulosin | 12 | $385 | $32 |
| Paroxetine | 18 | $352 | $20 |
| Fludrocortisone Acetate | 16 | $348 | $22 |
| Bupropion Hcl Sr | 26 | $327 | $13 |
| Carbamazepine | 12 | $319 | $27 |
| Diazepam | 46 | $270 | $6 |
| Pantoprazole | 12 | $266 | $22 |
| Zolpidem | 29 | $246 | $8 |
| Citalopram Hbr | 31 | $243 | $8 |
| Temazepam | 20 | $239 | $12 |
| Indomethacin | 12 | $217 | $18 |
| Risperidone | 12 | $198 | $16 |
| Diclofenac | 14 | $197 | $14 |
| Cyclobenzaprine | 12 | $168 | $14 |
| Ibuprofen | 11 | $159 | $14 |
| Trihexyphenidyl | 14 | $125 | $9 |
| Meloxicam | 18 | $62 | $3 |
2015: 73 drugs
| Oxycontin | 117 | $183,809 | $1,571 |
| Tecfidera | 23 | $125,822 | $5,471 |
| Gilenya | 13 | $74,994 | $5,769 |
| Opana Er | 20 | $37,935 | $1,897 |
| Lyrica | 55 | $23,934 | $435 |
| Fentanyl | 117 | $23,747 | $203 |
| Ampyra | 12 | $21,587 | $1,799 |
| Morphine Sulfate Er | 62 | $19,990 | $322 |
| Oxycodone-Acetaminophen | 104 | $19,976 | $192 |
| Oxycodone | 234 | $19,890 | $85 |
| Azilect | 30 | $19,517 | $651 |
| Vimpat | 17 | $17,257 | $1,015 |
| Hydrocodone-Acetaminophen | 266 | $16,703 | $63 |
| Oxymorphone | 12 | $8,432 | $703 |
| Duloxetine | 103 | $8,205 | $80 |
| Entacapone | 17 | $7,464 | $439 |
| Eszopiclone | 29 | $5,626 | $194 |
| Butrans | 11 | $5,265 | $479 |
| Carbidopa-Levodopa | 131 | $5,034 | $38 |
| Gabapentin | 154 | $4,998 | $32 |
| Hydromorphone | 98 | $4,942 | $50 |
| Voltaren | 11 | $4,906 | $446 |
| Endocet | 25 | $4,872 | $195 |
| Carbidopa-Levodopa Er | 41 | $4,774 | $116 |
| Maxalt Mlt | 11 | $4,686 | $426 |
| Methylphenidate Er | 12 | $4,615 | $385 |
| Linzess | 18 | $4,115 | $229 |
| Methadone | 92 | $3,415 | $37 |
| Venlafaxine | 40 | $3,311 | $83 |
| Methylphenidate | 50 | $3,282 | $66 |
| Ropinirole Er | 15 | $2,264 | $151 |
| Dextroamphetamine-Amphetamine | 30 | $2,152 | $72 |
| Methylphenidate La | 15 | $2,038 | $136 |
| Celecoxib | 11 | $1,968 | $179 |
| Levetiracetam | 61 | $1,901 | $31 |
| Lansoprazole | 13 | $1,726 | $133 |
| Pramipexole Dihydrochloride | 31 | $1,641 | $53 |
| Lorazepam | 63 | $1,641 | $26 |
| Tizanidine | 50 | $1,636 | $33 |
| Morphine Sulfate | 37 | $1,433 | $39 |
| Levothyroxine | 49 | $1,199 | $24 |
| Fluoxetine | 15 | $1,081 | $72 |
| Acetaminophen-Codeine | 13 | $1,052 | $81 |
| Donepezil | 21 | $1,016 | $48 |
| Mirtazapine | 40 | $1,001 | $25 |
| Clonazepam | 99 | $965 | $10 |
| Baclofen | 18 | $964 | $54 |
| Oxcarbazepine | 15 | $959 | $64 |
| Bupropion Xl | 18 | $945 | $53 |
| Quetiapine | 45 | $913 | $20 |
| Bupropion | 27 | $887 | $33 |
| Dilantin | 13 | $839 | $65 |
| Topiramate | 57 | $778 | $14 |
| Escitalopram | 60 | $771 | $13 |
| Lamotrigine | 65 | $763 | $12 |
| Tramadol | 30 | $751 | $25 |
| Zolpidem | 46 | $750 | $16 |
| Alprazolam | 94 | $738 | $8 |
| Sinemet Cr | 12 | $728 | $61 |
| Carisoprodol | 31 | $635 | $20 |
| Sertraline | 39 | $540 | $14 |
| Oxybutynin Chloride | 17 | $527 | $31 |
| Primidone | 21 | $466 | $22 |
| Fludrocortisone Acetate | 15 | $455 | $30 |
| Trazodone | 35 | $405 | $12 |
| Tamsulosin | 11 | $401 | $36 |
| Diazepam | 44 | $370 | $8 |
| Sumatriptan | 16 | $368 | $23 |
| Ondansetron | 17 | $341 | $20 |
| Risperidone | 15 | $320 | $21 |
| Temazepam | 23 | $234 | $10 |
| Indomethacin | 12 | $222 | $19 |
| Cyclobenzaprine | 12 | $118 | $10 |
2014: 69 drugs
| Oxycontin | 109 | $142,780 | $1,310 |
| Tecfidera | 17 | $85,029 | $5,002 |
| Gilenya | 13 | $65,032 | $5,002 |
| Betaseron | 12 | $54,849 | $4,571 |
| Opana Er | 13 | $32,475 | $2,498 |
| Lyrica | 71 | $25,317 | $357 |
| Oxycodone | 195 | $23,792 | $122 |
| Fentanyl | 99 | $23,648 | $239 |
| Lidocaine | 52 | $18,745 | $360 |
| Ampyra | 11 | $17,457 | $1,587 |
| Duloxetine | 88 | $16,845 | $191 |
| Vimpat | 17 | $16,747 | $985 |
| Hydrocodone-Acetaminophen | 288 | $12,783 | $44 |
| Endocet | 53 | $10,555 | $199 |
| Exelon | 30 | $10,463 | $349 |
| Oxycodone-Acetaminophen | 90 | $10,286 | $114 |
| Morphine Sulfate Er | 59 | $10,174 | $172 |
| Azilect | 14 | $10,049 | $718 |
| Hydromorphone | 113 | $6,525 | $58 |
| Metaxalone | 15 | $6,329 | $422 |
| Butrans | 18 | $6,050 | $336 |
| Carbidopa-Levodopa | 134 | $6,009 | $45 |
| Maxalt Mlt | 12 | $5,537 | $461 |
| Lunesta | 13 | $5,393 | $415 |
| Voltaren | 16 | $5,357 | $335 |
| Gabapentin | 133 | $4,896 | $37 |
| Eszopiclone | 19 | $4,580 | $241 |
| Methylphenidate | 64 | $3,799 | $59 |
| Levetiracetam | 77 | $3,470 | $45 |
| Carbidopa-Levodopa Er | 41 | $3,368 | $82 |
| Lamotrigine | 69 | $2,352 | $34 |
| Amphetamine Salt Combo | 25 | $2,288 | $92 |
| Morphine Sulfate | 57 | $2,227 | $39 |
| Methadone | 105 | $2,111 | $20 |
| Lansoprazole | 13 | $1,730 | $133 |
| Carisoprodol | 65 | $1,534 | $24 |
| Pramipexole Dihydrochloride | 27 | $1,530 | $57 |
| Bupropion | 28 | $1,372 | $49 |
| Venlafaxine | 18 | $1,341 | $75 |
| Tizanidine | 30 | $1,311 | $44 |
| Sumatriptan | 29 | $910 | $31 |
| Topiramate | 46 | $886 | $19 |
| Mirtazapine | 39 | $839 | $22 |
| Sinemet Cr | 12 | $829 | $69 |
| Clonazepam | 88 | $814 | $9 |
| Baclofen | 30 | $800 | $27 |
| Lorazepam | 64 | $799 | $12 |
| Quetiapine | 25 | $776 | $31 |
| Alprazolam | 103 | $763 | $7 |
| Acetaminophen-Codeine | 16 | $717 | $45 |
| Oxcarbazepine | 12 | $640 | $53 |
| Temazepam | 25 | $602 | $24 |
| Zolpidem | 67 | $496 | $7 |
| Escitalopram | 18 | $483 | $27 |
| Bupropion Xl | 11 | $441 | $40 |
| Levothyroxine | 22 | $408 | $19 |
| Trazodone | 38 | $391 | $10 |
| Sertraline | 38 | $382 | $10 |
| Oxybutynin Chloride | 11 | $319 | $29 |
| Primidone | 21 | $319 | $15 |
| Pantoprazole | 20 | $295 | $15 |
| Tramadol | 13 | $256 | $20 |
| Fluoxetine | 12 | $255 | $21 |
| Omeprazole | 14 | $240 | $17 |
| Diazepam | 27 | $205 | $8 |
| Risperidone | 16 | $201 | $13 |
| Citalopram Hbr | 28 | $194 | $7 |
| Naproxen | 16 | $158 | $10 |
| Clonidine | 12 | $63 | $5 |
2013: 72 drugs
| Oxycontin | 73 | $77,467 | $1,061 |
| Gilenya | 13 | $61,463 | $4,728 |
| Betaseron | 14 | $59,158 | $4,226 |
| Fentanyl | 141 | $36,856 | $261 |
| Cymbalta | 115 | $35,736 | $311 |
| Androgel | 23 | $19,256 | $837 |
| Avinza | 12 | $19,053 | $1,588 |
| Lyrica | 56 | $17,784 | $318 |
| Abilify | 17 | $16,600 | $976 |
| Oxycodone | 175 | $14,491 | $83 |
| Lidoderm | 20 | $13,785 | $689 |
| Vimpat | 16 | $12,751 | $797 |
| Azilect | 24 | $9,999 | $417 |
| Namenda | 20 | $9,485 | $474 |
| Hydrocodone-Acetaminophen | 253 | $8,919 | $35 |
| Oxycodone Hcl-Acetaminophen | 77 | $8,171 | $106 |
| Butrans | 20 | $7,800 | $390 |
| Hydromorphone | 93 | $7,464 | $80 |
| Entacapone | 12 | $6,812 | $568 |
| Lunesta | 26 | $6,640 | $255 |
| Exelon | 16 | $5,929 | $371 |
| Levetiracetam | 91 | $5,670 | $62 |
| Carbidopa-Levodopa | 103 | $5,146 | $50 |
| Fentanyl Citrate | 11 | $4,171 | $379 |
| Gabapentin | 100 | $3,733 | $37 |
| Endocet | 29 | $3,632 | $125 |
| Tizanidine | 45 | $3,383 | $75 |
| Carbidopa-Levodopa Er | 42 | $2,862 | $68 |
| Morphine Sulfate Er | 49 | $2,829 | $58 |
| Morphine Sulfate | 46 | $2,622 | $57 |
| Midodrine | 15 | $2,508 | $167 |
| Nasonex | 15 | $2,141 | $143 |
| Methadone | 92 | $1,754 | $19 |
| Bupropion | 37 | $1,735 | $47 |
| Galantamine Hbr | 12 | $1,671 | $139 |
| Escitalopram | 32 | $1,582 | $49 |
| Lamotrigine | 57 | $1,514 | $27 |
| Transderm-Scop | 22 | $1,444 | $66 |
| Hydroxyzine | 29 | $1,288 | $44 |
| Methylphenidate Er | 12 | $1,180 | $98 |
| Amantadine | 13 | $1,156 | $89 |
| Acetaminophen-Codeine | 17 | $1,108 | $65 |
| Methylphenidate | 27 | $1,103 | $41 |
| Alprazolam | 126 | $963 | $8 |
| Amphetamine Salt Combo | 15 | $917 | $61 |
| Clonazepam | 82 | $818 | $10 |
| Quetiapine | 50 | $806 | $16 |
| Carisoprodol | 52 | $796 | $15 |
| Donepezil | 51 | $766 | $15 |
| Lorazepam | 45 | $765 | $17 |
| Sertraline | 58 | $652 | $11 |
| Temazepam | 27 | $636 | $24 |
| Zolpidem | 77 | $447 | $6 |
| Topiramate | 22 | $446 | $20 |
| Fluoxetine | 22 | $446 | $20 |
| Risperidone | 20 | $431 | $22 |
| Baclofen | 23 | $405 | $18 |
| Primidone | 12 | $394 | $33 |
| Levothyroxine | 29 | $362 | $12 |
| Omeprazole | 23 | $320 | $14 |
| Pantoprazole | 13 | $282 | $22 |
| Cyclobenzaprine | 20 | $271 | $14 |
| Mirtazapine | 25 | $261 | $10 |
| Trazodone | 30 | $234 | $8 |
| Phenytoin Sodium Extended | 11 | $205 | $19 |
| Tramadol | 12 | $183 | $15 |
| Azathioprine | 12 | $182 | $15 |
| Diazepam | 30 | $165 | $6 |
| Prochlorperazine Maleate | 15 | $143 | $10 |
| Citalopram Hbr | 13 | $99 | $8 |
| Prednisone | 14 | $74 | $5 |
| Amitriptyline | 11 | $59 | $5 |
Money from drug and device companies
$15 in 2025
| 2025 | 1 | 1 | None | $15 |
| 2024 | 2 | 11 | None | $165 |
| 2023 | 3 | 29 | None | $390 |
| 2022 | 2 | 18 | None | $159 |
| 2021 | 1 | 1 | None | $14 |
| 2020 | 1 | 2 | None | $30 |
| 2019 | 2 | 2 | None | $40 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurocrine BioSciences | Ingrezza | $15 | 1 payment
|
See the published payment
| Neurocrine BioSciences | Meals · 2025-02-19 | Ingrezza | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $165
| Pfizer | Nurtec Odt | $145 | 10 payments
|
| Neurocrine Biosciences | Ingrezza | $19 | 1 payment
|
2023: $390
| AbbVie | Qulipta | $245 | 16 payments
|
| Pfizer | Nurtec Odt | $131 | 12 payments
|
| Lilly USA | Emgality | $14 | 1 payment
|
2022: $159
| Abbvie | Qulipta | $133 | 16 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $26 | 2 payments
|
2021: $14
| Ucb | Vimpat | $14 | 1 payment
|
2020: $30
| E.R. Squibb & Sons L.L.C. | Zeposia | $30 | 2 payments
|
2019: $40
| Teva Pharmaceuticals USA | Austedo | $22 | 1 payment
|
| Ucb | Vimpat | $18 | 1 payment
|
Professional record
- NPI
- 1548450448
- Licence
- CA A77824California A77824: Current · expires 2027-04-30
- Trained
- University of California, San Francisco School of Medicine, 1997 · 29 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2084P2900X (2084P2900X)
- Mailing address
- 1456 Professional Dr Ste 402, Petaluma, CA, 94954
- NPI first listed
- 2007-07-26
- NPI last updated
- 2022-07-08
- NPI record certified
- 2022-07-08
This is when the NPI record was last certified, not a medical board exam.